Cargando…

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States

BACKGROUND: The objective of this study was to characterize hospitalized coronavirus disease 2019 (COVID-19) patients and describe their real-world treatment patterns and outcomes over time. METHODS: Adult patients hospitalized on May 1, 2020–December 31, 2020 with a discharge diagnosis of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozaffari, Essy, Chandak, Aastha, Zhang, Zhiji, Liang, Shuting, Gayle, Julie, Thrun, Mark, Gottlieb, Robert L, Kuritzkes, Daniel R, Sax, Paul E, Wohl, David A, Casciano, Roman, Hodgkins, Paul, Haubrich, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522394/
https://www.ncbi.nlm.nih.gov/pubmed/34984212
http://dx.doi.org/10.1093/ofid/ofab498
_version_ 1784585080178475008
author Mozaffari, Essy
Chandak, Aastha
Zhang, Zhiji
Liang, Shuting
Gayle, Julie
Thrun, Mark
Gottlieb, Robert L
Kuritzkes, Daniel R
Sax, Paul E
Wohl, David A
Casciano, Roman
Hodgkins, Paul
Haubrich, Richard
author_facet Mozaffari, Essy
Chandak, Aastha
Zhang, Zhiji
Liang, Shuting
Gayle, Julie
Thrun, Mark
Gottlieb, Robert L
Kuritzkes, Daniel R
Sax, Paul E
Wohl, David A
Casciano, Roman
Hodgkins, Paul
Haubrich, Richard
author_sort Mozaffari, Essy
collection PubMed
description BACKGROUND: The objective of this study was to characterize hospitalized coronavirus disease 2019 (COVID-19) patients and describe their real-world treatment patterns and outcomes over time. METHODS: Adult patients hospitalized on May 1, 2020–December 31, 2020 with a discharge diagnosis of COVID-19 were identified from the Premier Healthcare Database. Patient and hospital characteristics, treatments, baseline severity based on oxygen support, length of stay (LOS), intensive care unit (ICU) utilization, and mortality were examined. RESULTS: The study included 295657 patients (847 hospitals), with median age of 66 (interquartile range, 54–77) years. Among each set of demographic comparators, the majority were male, white, and over 65. Approximately 85% had no supplemental oxygen charges (NSOc) or low-flow oxygen (LFO) at baseline, whereas 75% received no more than NSOc or LFO as maximal oxygen support at any time during hospitalization. Remdesivir (RDV) and corticosteroid treatment utilization increased over time. By December, 50% were receiving RDV and 80% were receiving corticosteroids. A higher proportion initiated COVID-19 treatments within 2 days of hospitalization in December versus May (RDV, 87% vs 40%; corticosteroids, 93% vs 62%; convalescent plasma, 68% vs 26%). There was a shift toward initiating RDV in patients on NSOc or LFO (68.0% [May] vs 83.1% [December]). Median LOS decreased over time. Overall mortality was 13.5% and it was highest for severe patients (invasive mechanical ventilation/extracorporeal membrane oxygenation [IMV/ECMO], 53.7%; high-flow oxygen/noninvasive ventilation [HFO/NIV], 32.2%; LFO, 11.7%; NSOc, 7.3%). The ICU use decreased, whereas mortality decreased for NSOc and LFO. CONCLUSIONS: Clinical management of COVID-19 is rapidly evolving. This large observational study found that use of evidence-based treatments increased from May to December 2020, whereas improvement in outcomes occurred over this time-period.
format Online
Article
Text
id pubmed-8522394
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85223942021-10-20 Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States Mozaffari, Essy Chandak, Aastha Zhang, Zhiji Liang, Shuting Gayle, Julie Thrun, Mark Gottlieb, Robert L Kuritzkes, Daniel R Sax, Paul E Wohl, David A Casciano, Roman Hodgkins, Paul Haubrich, Richard Open Forum Infect Dis Major Articles BACKGROUND: The objective of this study was to characterize hospitalized coronavirus disease 2019 (COVID-19) patients and describe their real-world treatment patterns and outcomes over time. METHODS: Adult patients hospitalized on May 1, 2020–December 31, 2020 with a discharge diagnosis of COVID-19 were identified from the Premier Healthcare Database. Patient and hospital characteristics, treatments, baseline severity based on oxygen support, length of stay (LOS), intensive care unit (ICU) utilization, and mortality were examined. RESULTS: The study included 295657 patients (847 hospitals), with median age of 66 (interquartile range, 54–77) years. Among each set of demographic comparators, the majority were male, white, and over 65. Approximately 85% had no supplemental oxygen charges (NSOc) or low-flow oxygen (LFO) at baseline, whereas 75% received no more than NSOc or LFO as maximal oxygen support at any time during hospitalization. Remdesivir (RDV) and corticosteroid treatment utilization increased over time. By December, 50% were receiving RDV and 80% were receiving corticosteroids. A higher proportion initiated COVID-19 treatments within 2 days of hospitalization in December versus May (RDV, 87% vs 40%; corticosteroids, 93% vs 62%; convalescent plasma, 68% vs 26%). There was a shift toward initiating RDV in patients on NSOc or LFO (68.0% [May] vs 83.1% [December]). Median LOS decreased over time. Overall mortality was 13.5% and it was highest for severe patients (invasive mechanical ventilation/extracorporeal membrane oxygenation [IMV/ECMO], 53.7%; high-flow oxygen/noninvasive ventilation [HFO/NIV], 32.2%; LFO, 11.7%; NSOc, 7.3%). The ICU use decreased, whereas mortality decreased for NSOc and LFO. CONCLUSIONS: Clinical management of COVID-19 is rapidly evolving. This large observational study found that use of evidence-based treatments increased from May to December 2020, whereas improvement in outcomes occurred over this time-period. Oxford University Press 2021-09-28 /pmc/articles/PMC8522394/ /pubmed/34984212 http://dx.doi.org/10.1093/ofid/ofab498 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Mozaffari, Essy
Chandak, Aastha
Zhang, Zhiji
Liang, Shuting
Gayle, Julie
Thrun, Mark
Gottlieb, Robert L
Kuritzkes, Daniel R
Sax, Paul E
Wohl, David A
Casciano, Roman
Hodgkins, Paul
Haubrich, Richard
Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
title Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
title_full Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
title_fullStr Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
title_full_unstemmed Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
title_short Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
title_sort clinical management of hospitalized coronavirus disease 2019 patients in the united states
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522394/
https://www.ncbi.nlm.nih.gov/pubmed/34984212
http://dx.doi.org/10.1093/ofid/ofab498
work_keys_str_mv AT mozaffariessy clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT chandakaastha clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT zhangzhiji clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT liangshuting clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT gaylejulie clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT thrunmark clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT gottliebrobertl clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT kuritzkesdanielr clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT saxpaule clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT wohldavida clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT cascianoroman clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT hodgkinspaul clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates
AT haubrichrichard clinicalmanagementofhospitalizedcoronavirusdisease2019patientsintheunitedstates